Evidence map›Paper›PMID 38709548›Full record

ArticleJMIR formative research2024

Integrating Virtual Mindfulness-Based Stress Reduction Into Inflammatory Bowel Disease Care: Mixed Methods Feasibility Trial.

Kaitlyn Delaney Chappell, Diana Meakins, Melanie Marsh-Joyal, Allison Bihari, Karen J Goodman, Jean-Michel Le Melledo, Allen Lim, Farhad Peerani, Karen Ivy Kroeker

Abstract read
In one paragraph

Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaitlyn Delaney ChappellDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0001-6695-7305
Diana MeakinsDepartment of Psychiatry, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0009-0008-0065-8650
Melanie Marsh-JoyalDepartment of Psychiatry, Royal Alexandra Hospital, Edmonton, AB, Canada.ORCID https://orcid.org/0009-0007-4813-7718
Allison BihariDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-7315-9368
Karen J GoodmanDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-3790-3217
Jean-Michel Le MelledoDepartment of Psychiatry, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0009-0009-1636-0901
Allen LimDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0009-0008-9610-7369
Farhad PeeraniDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0003-1865-3192
Karen Ivy KroekerDivision of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID https://orcid.org/0000-0002-3886-4213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with inflammatory bowel disease (IBD) experience cycles of aggressive physical symptoms including abdominal pain, diarrhea, and fatigue. These acute symptoms regress and return, and chronic symptoms and complications often linger. The nature of the disease can also cause individuals to experience psychological distress including symptoms of anxiety and depression; however, unlike the physical symptoms of IBD, these psychological symptoms often remain untreated.

objectiveThis study aims to evaluate the feasibility, acceptability, and effectiveness of virtual mindfulness-based stress reduction (v-MBSR) for adults with IBD.

methodsIBD patients with self-reported anxiety or depression were recruited from clinics in Alberta, Canada to participate in an 8-week v-MSBR intervention. Eligible patients participated in v-MBSR delivered by psychiatrists using a videoconferencing platform. Primary feasibility outcomes included trial uptake, adherence, attendance, and attrition rates. Secondary effectiveness outcomes included measures of anxiety, depression, quality of life (QoL), and mindfulness. Effectiveness data were collected at 3 time points: baseline, at intervention completion, and 6 months after completion. To further assess feasibility and acceptability, participants were invited to participate in a semistructured interview after completing v-MBSR.

resultsA total of 16 of the 64 (25%) referred patients agreed to participate in v-MBSR with the most common reason for decline being a lack of time while 7 of the 16 (43.8%) participants completed the program and experienced encouraging effects including decreased anxiety and depression symptoms and increased health-related QoL with both improvements persisting at 6-month follow-up. Participants described improved coping strategies and disease management techniques as benefits of v-MBSR.

conclusionsPatients with IBD were interested in a psychiatrist-led virtual anxiety management intervention, but results demonstrate v-MBSR may be too time intensive for some patients with IBD patients. v-MBSR was acceptable to those who completed the intervention, and improvements to anxiety, depression, and QoL were promising and sustainable. Future studies should attempt to characterize the patients with IBD who may benefit most from interventions like v-MBSR.

Indexed as

adultadultsanxietyCanadacliniccopingcoping strategydepressioneffectivenessfeasibility trialhealth facilityIBDinflammatory bowel diseasemental healthmultidisciplinary carepsychiatristpsychiatristspsychosocial carequality of carequality of lifesemistructured interviewvideoconferencingvirtual mindfulnessv-MBSR

Identifiers

PMID38709548
PMCPMC11106704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.